HCT Co., Ltd. (KOSDAQ:072990)
6,200.00
+140.00 (2.31%)
At close: Feb 5, 2026
HCT Co., Ltd. Revenue
HCT Co., Ltd. had revenue of 28.07B KRW in the quarter ending September 30, 2025, with 15.95% growth. This brings the company's revenue in the last twelve months to 109.24B, up 24.32% year-over-year. In the year 2024, HCT Co., Ltd. had annual revenue of 94.41B with 27.38% growth.
Revenue (ttm)
109.24B
Revenue Growth
+24.32%
P/S Ratio
0.78
Revenue / Employee
225.23M
Employees
485
Market Cap
85.30B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 94.41B | 20.29B | 27.38% |
| Dec 31, 2023 | 74.11B | 7.00B | 10.42% |
| Dec 31, 2022 | 67.11B | 3.84B | 6.08% |
| Dec 31, 2021 | 63.27B | 9.89B | 18.53% |
| Dec 31, 2020 | 53.38B | 5.96B | 12.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INITECH | 294.59B |
| CTK Co., Ltd | 91.15B |
| Amicogen | 87.97B |
| DAVOLINK | 62.39B |
| Genesem | 57.76B |
| TRUEN | 51.69B |
| Incross | 50.62B |
| GL Pharm Tech | 34.30B |